+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A KCR1 variant implicated in susceptibility to the long QT syndrome



A KCR1 variant implicated in susceptibility to the long QT syndrome



Journal of Molecular and Cellular Cardiology 50(1): 50-57



The acquired long QT syndrome (aLQTS) is frequently associated with extrinsic and intrinsic risk factors including therapeutic agents that inadvertently inhibit the KCNH2 K(+) channel that underlies the repolarizing I(Kr) current in the heart. Previous reports demonstrated that K(+) channel regulator 1 (KCR1) diminishes KCNH2 drug sensitivity and may protect susceptible patients from developing aLQTS. Here, we describe a novel variant of KCR1 (E33D) isolated from a patient with ventricular fibrillation and significant QT prolongation. We recorded the KCNH2 current (I(KCNH2)) from CHO-K1 cells transfected with KCNH2 plus wild type (WT) or mutant KCR1 cDNA, using whole cell patch-clamp techniques and assessed the development of I(KCNH2) inhibition in response to well-characterized KCNH2 inhibitors. Unlike KCR1 WT, the E33D variant did not protect KCNH2 from the effects of class I antiarrhythmic drugs such as quinidine or class III antiarrhythmic drugs including dofetilide and sotalol. The remaining current of the KCNH2 WT+KCR1 E33D channel after 100 pulses in the presence of each drug was similar to that of KCNH2 alone. Simulated conditions of hypokalemia (1mM [K(+)](o)) produced no significant difference in the fraction of the current that was protected from dofetilide inhibition with KCR1 WT or E33D. The previously described α-glucosyltransferase activity of KCR1 was found to be compromised in KCR1 E33D in a yeast expression system. Our findings suggest that KCR1 genetic variations that diminish the ability of KCR1 to protect KCNH2 from inhibition by commonly used therapeutic agents constitute a risk factor for the aLQTS.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051067346

Download citation: RISBibTeXText

PMID: 20950623

DOI: 10.1016/j.yjmcc.2010.10.007


Related references

An allelic variant at the ATM locus is implicated in breast cancer susceptibility. Genetic Testing 1(3): 165-170, 1997

Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano-Ward syndrome under double mutations and acquired long QT syndrome under heterozygote. Journal of Cardiology 70(1): 74-79, 2017

Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome. Clinical Endocrinology 65(1): 64-70, 2006

Prevalence and spectrum of large deletions or duplications in the major long QT syndrome-susceptibility genes and implications for long QT syndrome genetic testing. American Journal of Cardiology 106(8): 1124-1128, 2010

Variation at the calpain 10 gene implicated in type 2 diabetes susceptibility, plays no role in the pathogenesis of polycystic ovary syndrome. American Journal of Human Genetics 69(4 Suppl.): 567, 2001

ABC transporters and the proteasome complex are implicated in susceptibility to Stevens-Johnson syndrome and toxic epidermal necrolysis across multiple drugs. Plos one 10(6): E0131038, 2015

Spectrum and Prevalence of CALM1-, CALM2-, and CALM3-Encoded Calmodulin Variants in Long QT Syndrome and Functional Characterization of a Novel Long QT Syndrome-Associated Calmodulin Missense Variant, E141G. Circulation. Cardiovascular Genetics 9(2): 136-146, 2016

Investigation of cardiac SCN5A inactivation gating Insights from mutations implicated in the Long-QT Syndrome. Biophysical Journal 82(1 Part 2): 358a, 2002

Andersen syndrome: the newest variant of the hereditary-familial long QT syndrome. Annals of Noninvasive Electrocardiology 9(2): 175-179, 2004

A variant of the congenital long-QT syndrome, the Jervell Lange-Nielsen syndrome, maps not to HERG and SCN5A. American Journal of Human Genetics 59(4 Suppl. ): A104, 1996

A variant of congenital long QT syndrome, the Jervell Lange-Nielsen syndrome, maps not to HERG and SCN5A. European Heart Journal 17(ABSTR Suppl. ): 125, 1996

Does the locus on chromosome 11 implicated in susceptibility to HLA-DR4 dependent type I diabetes mellitus also affect susceptibility to rheumatoid arthritis?. Annals of the Rheumatic Diseases 51(11): 1250-1251, 1992

The germline MLH1 K618A variant and susceptibility to Lynch syndrome-associated tumors. Journal of Molecular Diagnostics 14(3): 264-273, 2012

Childhood-onset PsA in Down syndrome with psoriasis susceptibility variant CARD14 rs11652075. Rheumatology 54(1): 197-199, 2015

A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia. Pharmacogenomics Journal 4(1): 49-53, 2003